norgestrel and Venous Thromboembolism

norgestrel has been researched along with Venous Thromboembolism in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Del Savio, MC; Facchinetti, F; Grandi, G1
Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK1
Kelver, ME; Phelps, JY1
Hagberg, KW; Hernandez, RK; Jick, SS; Kaye, JA1
Dore, DD; Loughlin, J; Norman, H; Seeger, JD1
Hagberg, KW; Jick, SS; Kaye, JA1
Burke, AE; Espey, E; Raymond, EG1
Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M1
Mansour, D; Shapiro, S; Szarewski, A1

Reviews

2 review(s) available for norgestrel and Venous Thromboembolism

ArticleYear
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.
    Expert review of clinical pharmacology, 2021, Volume: 14, Issue:2

    Topics: Animals; Contraceptive Agents, Hormonal; Female; Humans; Levonorgestrel; Norgestrel; Risk; Venous Thromboembolism

2021
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Contraception, 2017, Volume: 95, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult

2017

Other Studies

7 other study(ies) available for norgestrel and Venous Thromboembolism

ArticleYear
Confronting the legal risks of prescribing the contraceptive patch with ongoing litigation.
    Obstetrics and gynecology, 2009, Volume: 113, Issue:3

    Topics: Contraceptives, Oral, Combined; Drug Approval; Drug Combinations; Drug Labeling; Ethinyl Estradiol; Gynecology; Humans; Informed Consent; Legislation, Drug; Liability, Legal; Norgestrel; Physicians; United States; Venous Thromboembolism

2009
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.
    Contraception, 2010, Volume: 81, Issue:1

    Topics: Adolescent; Adult; Case-Control Studies; Confidence Intervals; Contraceptives, Oral; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norgestrel; Odds Ratio; Product Surveillance, Postmarketing; United States; Venous Thromboembolism

2010
Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.
    Contraception, 2010, Volume: 81, Issue:5

    Topics: Administration, Cutaneous; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Myocardial Infarction; Norgestrel; Risk Assessment; Stroke; Venous Thromboembolism

2010
ORTHO EVRA and venous thromboembolism: an update.
    Contraception, 2010, Volume: 81, Issue:5

    Topics: Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Venous Thromboembolism

2010
Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Obstetrics and gynecology, 2012, Volume: 119, Issue:5

    Topics: Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Labeling; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Assessment; Venous Thromboembolism

2012
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
    Contraception, 2013, Volume: 87, Issue:1

    Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult

2013
Another flawed database study.
    Contraception, 2013, Volume: 87, Issue:4

    Topics: Androstenes; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Venous Thromboembolism

2013
chemdatabank.com